Trilegal and Canadian law firm Osler, Hoskin & Harcourt LLP (Osler) advised Montreal-based CRO JSS Medical Research in its acquisition of CRO Max Neeman Medical International, which was advised by AZB & Partners..The deal is valued at 9.5 crore ($1.5 million)..The Trilegal team was led by Partner Charandeep Kaur along with Counsel Ramakant Rai and Associate Jatin Vyas, while the Osler team was led by Partner Shahir Guindi and Associate Geneviève Burdon..The AZB team included Partners Anil Kasturi and Niladari Maulik and Associate Siddharth Khanna..According to news reports, JSS Medical is the largest Canadian owned CRO and is currently conducting research studies in over 20 countries around the world for its clients, which include the top 25 global pharmaceutical companies and biotech/medical device companies..This acquisition enables JSS to provide its large pharmaceutical clients with its services to their regional affiliates in India and surrounding regions, according to the press release..Image taken from here.
Trilegal and Canadian law firm Osler, Hoskin & Harcourt LLP (Osler) advised Montreal-based CRO JSS Medical Research in its acquisition of CRO Max Neeman Medical International, which was advised by AZB & Partners..The deal is valued at 9.5 crore ($1.5 million)..The Trilegal team was led by Partner Charandeep Kaur along with Counsel Ramakant Rai and Associate Jatin Vyas, while the Osler team was led by Partner Shahir Guindi and Associate Geneviève Burdon..The AZB team included Partners Anil Kasturi and Niladari Maulik and Associate Siddharth Khanna..According to news reports, JSS Medical is the largest Canadian owned CRO and is currently conducting research studies in over 20 countries around the world for its clients, which include the top 25 global pharmaceutical companies and biotech/medical device companies..This acquisition enables JSS to provide its large pharmaceutical clients with its services to their regional affiliates in India and surrounding regions, according to the press release..Image taken from here.